MOLLIE TANNER: Open Payments
NPI 1902468341 · CUSHING, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$173 in 9 payments from 8 companies in 2025. Trend: 2023 $80 · 2024 $256 · 2025 $173
Food & beverage: $173
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Astellas Pharma US Inc | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| Boston Scientific Corporation | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| ABBVIE INC. | 1 | $18 |
Products named: XIFAXAN, Veozah, MOUNJARO, Cologuard Collection Kit, WaveWriter Alpha Prime 16, TRELEGY ELLIPTA, AIRSUPRA, VRAYLAR.
Industry payments across OK — which companies pay providers there.
